Advent International to merge Cohance Lifesciences with Suven Pharma
HYDERABAD: Following the acquisition of Hyderabad-based Suven Pharma last year, global private equity giant Advent International is now merging the un.
Stay updated with breaking news from Berhyanda Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HYDERABAD: Following the acquisition of Hyderabad-based Suven Pharma last year, global private equity giant Advent International is now merging the un.
Advent also announced the new Board of Directors and management team for Suven Pharma, including Sudhir Kumar Singh as CEO
The approval is for the acquisition of up to 76.1 percent stake in Suven Pharmaceuticals by Cyprus-based Berhyanda Ltd.
Proposal has been evaluated by Sebi, RBI, CCI and other relevant agencies, after meeting of Cabinet Committee on Economic Affairs
Suven Pharmaceuticals shares zoomed 8.53% to a fresh high of Rs 557.40 against the previous close of Rs 513.55 on BSE